Surgical treatment of Parkinson's disease

Current Opinion in Neurology

Volumn 12, Issue 4, 1999, Pages 417-425

  Krack, Paul ^a   Hamel, Wolfgang ^a   Mehdorn, Hubertus Maximilian ^a   Deuschl, Günther ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEPTH STIMULATION; GLOBUS PALLIDUS; HUMAN; NEUROSURGERY; PALLIDOTOMY; PARKINSON DISEASE; REVIEW; SUBTHALAMIC NUCLEUS; THALAMUS;

ELECTRIC STIMULATION; GLOBUS PALLIDUS; HUMANS; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; THALAMUS;

EID: 0033397405     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199908000-00008     Document Type: Review

References (138)

1. Speelman JD, Bosch DA. Resurgence of functional neurosurgery for Parkinson's disease: a historical perspective. Mov Disord 1998; 13:582-588.
2. Gabriel EM, Nashold BS. Evolution of neuroablative surgery for involuntary movement disorders: an historical review. Neurosurgery 1998; 42:575-591.
3. Benabid AL, Caparros-Lefebvre D, Pollak P. History of surgery for movement disorders. In: Neurosurgical treatment of movement disorders. Germano IM (editor). Park Ridge: American Association of Neurosurgeons; 1998. pp. 19-36.
4. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992; 76:53-61.
5. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990; 13:281-285.
6. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, de Rougemont J. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991; 337:403-406.
7. Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994; 35:1126-1130.
8. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Lebas JF, Brousolle E, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995; 345:91-95.
9. Kondziolka D, Dempsey P, Lundsford L. Comparison between magnetic resonance imaging and computed tomography for stereotactic co-ordinated termination. Neurosurgery 1992; 30:402-407.
10. Baron MS, Vitek JL, Bakay RAE, Green J, Kaneoke Y, Hashimoto T, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996; 40:355-366.
11. Lang AE, Lozano AM, Montgomery EB, Duff J, Tasker RR, Hutchison WD. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997; 337:1036-1042.
12. Hariz MI, Bergenheim AT, Fodstad H. Crusade for microelectrode guidance in pallidotomy [response to Vitek JL, Bakay RA, DeLong MR]. J Neurosurg 1999; 90:175-179.
13. Vitek JL, Bakay RA, DeLong MR. Crusade for microelectrode guidance in pallidotomy-Response [letter]. J Neurosurg 1999; 90:177-179.
14. Carroll CB, Scott R, Davies LE, Aziz T. The pallidotomy debate. Br J Neurosurg 1998; 12:146-150.
15. Kumar R, Lozano AM, Montgomery E, Lang AE. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord 1998; 13 (Suppl.1):73-82.
16. Scott R, Gregory R, Hines N, Carroll C, Hyman N, Papanasstasiou V, et al. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. Brain 1998; 121:659-675.
17. Pollak P, Benabid AL, Krack P, Limousin P, Benazzouz A. Deep brain stimulation. In: Parkinson's disease and movement disorders, 3rd edn. Jankovic J, Tolosa E (editors). Baltimore: Williams & Wilkins; 1998. pp. 1085-1101.
18. Siegfried J, Taub E. Comparative study of complications of lesioning vs stimulation after stereotactic operations for movement disorders in a personal series from 1987 to 1997 [abstract]. Acta Neurochirurg 1998; 140:839.
19. Benabid AL, Benazzouz A, Gao D, Hoffmann D, Limousin P, Koudsie A, et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus and of other nuclei as a treatment for Parkinson's disease. Techniques Neurosurg 1999; 5:5-30.
20. Ardouin C, Pillon B, Peiffer E, Bejjani P, Limousin P, Darnier P, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions. A consecutive series of 62 patients. Ann Neurol 1999 (in press).
21. Benabid AL, Pollak P, Gao D, Hoffmann D, Limousin P, Gay E, et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996; 84:203-214.
22. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339:1105-1111. This is the first study in a larger consecutive (n = 20) series followed up for 12 months, starting with the very first patient treated by bilateral stimulation of the STN. The study confirms the preliminary reports from this group that demonstrate a major improvement in off-period motor score (UPDRS 111,60%), painful off-period dystonia (resolved in 75%, decreased in the remaining patients) and global activities of daily living (Schwab and England scale increased from 29% to 74% on average). In addition, dopaminergic drugs could be reduced by half with a subsequent reduction in dyskinesias. Five patients were followed for more than 36 months, and the treatment had a continuing benefit in all of them. The therapy can be considered as a breakthrough for Parkinson's disease patients with advanced stage disease, suffering from severe long-term motor complications of dopaminergic treatment.
23. Kumar R, Lozano AM, Kim YJ, Hutchison WD, Sime E, Halket E, Lang AE. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998; 51:850-855. This study confirms the results of Limousin et al. [22] in a smaller series, but with double-blind evaluation. In contrast to the Grenoble experience, the Toronto group found a significant improvement in on-period motor function. Unlike in the study by Limousin et al., however, the patients were not assessed with suprathreshold levodopa dosage, which may account for this difference.
24. Ghika J, Villemure JG, Fankhauser H, Favre J, Assal G, Ghika-Scmid F. Efficiency and safety of bilateral contemporaneous palidial stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a two-year follow-up review. J Neurosurg 1998; 89:713-718. Major improvements (>50%) in off-period motor score and activities of daily living related to bilateral GPi-stimulation persisted 2 years after surgery. Signs of decreased efficacy started to be seen after 12 months, however, requiring an increase in medication, leading to partial loss of the initial antidyskinetic effect.
25. Volkmann J, Sturm V, Weiss P, Kappler J, Voges J, Koulousakis A, et al. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease. Ann Neurol 1998; 44:953-961.
26. Dogali M, Fazzini E, Kolodny E, Eidelberg D, Sterio D, Devinsky O, Beric A. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995; 45:753-761.
27. Kopyov O, Jacques D, Duma C, Buckwalter G, Kopyov A, Lieberman A, Copcutt B. Microelectrode-guided posteroventral medial radiofrequency pallidotomy for Parkinson's disease. J Neurosurg 1997; 87:52-59.
28. Kishore A, Turnbull IM, Snow BJ, de la Fuente-Fernandez R, Schulzer M, Mak E, et al. Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-months follow-up with additional 1-year observations. Brain 1997; 120:729-737.
29. Uitti R, Wharen RE, Turk MF, Lucas JA, Finton MJ, Graff-Radford NR, et al. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology 1997; 49:1072-1077.
30. Samuel M, Caputo E, Brooks DJ, Schrag A, Scaravilli T, Branston NM, et al. A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. Brain 1998; 121:59-75.
31. Ondo WG, Jankovic J, Lai EC, Sankhla C, Khan M, Ben-Arie L, et al. Assessment of motor function after stereotactic pallidatomy. Neurology 1998; 50:266-270.
32. Shannon KM, Penn RD, Kroin JS, Adler CH, Janko KA, York M, Cox SJ. Stereotactic pallidotomy for the treatment of Parkinson's disease: efficacy and adverse effects at 6 months in 26 patients. Neurology 1998; 50:434-438.
33. Giller CA, Dewey RB, Ginsburg MI, Mendelsohn DB, Berk AM. Stereotactic pallidotomy and thalamotomy using individual variations of anatomic landmarks for localization. Neurosurgery 1998; 42:56-62.
34. Lang AE. Pallidal surgery: pallidotomy vs. pallidal stimulation: which to choose? In: Teaching courses of the American Academy Meeting 1999. St Paul: American Academy of Neurology; 1999. pp. 1-7.
35. Uitti RJ, Wharen RE, Turk MF. Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinson's disease. Neurology 1998; 51:1755-1757.
36. Skalabrin EJ, Laws ER, Bennett JP. Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease. Mov Disord 1998; 13:775-781.
37. Giroux ML, Vitek JL. Pallidotomy: a treatment for Parkinsonian tremor? In: Pallidal surgery for the treatment of Parkinson's disease and movement disorders. Krauss JK, Grossman RG, Jankovic J (editors). Philadelphia: Lippincott-Raven; 1998. pp. 179-189.
38. Lozano AM, Lang AE, Hutchison WD. Pallidotomy for tremor. Mov Disord 1998; 13 (Suppl. 3):107-110.
39. Merello M, Nouzeilles MI, Cammarotta A, Pikielny R, Leiguarda R. Changes in the motor response to acute L-dopa challenge after unilateral microelectrode-guided posteroventral pallidotomy. Clin Neuropharmacol 1998; 21:135-138.
40. Limousin P, Brown RG, Jahanshahi M, Asselman P, Quinn NP, Thomas D, et al. The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease. Brain 1999; 122:315-327. Pallidotomy had no effect on initiation time in unwarned simple and choice reaction time tasks, whereas movement time measured during the same task was improved. Movement times also improved for isometric and ballistic movements. In contrast, repetitive, distal and fine movements measured in finger-tapping and pegboard tasks were not improved after pallidotomy. Preparatory processes were investigated using both behavioural and electrophysiological measures. The data suggest that pallidotomy improved mainly the later stages of movement preparation and the execution of proximal movements with the contralesional limb. This paper provides detailed quantitative data on the impact of PVP on upper limb akinesia.
41. Kimber TE, Tsai CS, Semmler J, Brophy BP, Thompson PD. Voluntary movements after pallidotomy in severe Parkinson's disease. Brain 1999; 122:895-906.
42. Jankovic J, Ben-Arie L, Schwartz K, Chen K, Khan M, Lai EC, et al. Movement and reaction times and fine coordination tasks following pallidotomy. Mov Disord 1999; 14:57-62.
43. Bennett KMB, O'Sullivan JD, Peppard RF, McNeill PM, Castiello U. The effect of unilateral posteroventral pallidotomy on the kinematics of the reach to grasp movement. J Neurol Neurosurg Psychiatry 1998; 65:479-487.
44. Pfann K, Penn RD, Shannon KM, Corcos DM. Pallidotomy and bradykinesia. Implications for basal ganglia function. Neurology 1998; 51:796-803.
45. Merello M, Nouzeilles MI, Cammarota A, Betti O, Leiguarda R. Comparison of 1-year follow-up evaluations of patients with indication for pallidotomy who did not undergo surgery versus patients with Parkinson's disease who did undergo pallidotomy: a case control study. Neurosurgery 1999; 44:467-468.
46. Poewe W, Wenning GK. The natural history of Parkinson's disease. Neurology 1996, 47 (Suppl. 3):146-152.
47. Klawans HL. Individual manifestations of Parkinson's disease after ten or more years of levodopa. Mov Disord 1986; 3:187-192.
48. Fazzini E, Dogali M, Sterio D, Eidelberg D, Beric A. Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy. Neurology 1997; 48:1273-1277.
49. Samii A, Turnbull IM, Kishore A, Schulzer M, Mak E, Yardley S, Calne DB: Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year folow-up study. Brain 1999, 122:417-425. Two years after pallidotomy improvements in dyskinesia and tremor were preserved, whereas the initial improvements in most other deficits disappeared, either because of progression of the disease or loss of the early efficacy.
50. Kondziolka D, Bonaroti E, Baser S, Brandt F, Kim YS, Lunsford LD. Outcomes after stereotactically guided pallidotomy for advanced Parkinson's disease. J Neurosurg 1999; 90:197-202.
51. Dalvi A, Winfield L, Yu Q, Côté L, Goodman RR, Pullman SL. Stereotactic posteroventral pallidotomy: clinical methods and results at 1-year follow up. Mov Disord 1999; 14:256-261.
52. Svennilson E, Torvik A, Lowe R, Leksell L. Treatment of Parkinsonism by stereotactic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatr Neurol Scand 1960; 35:358-377.
53. Laitinen LV, Bergenheim AT, Hariz MI. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotactic Funct Neurosurg 1992; 58:14-21.
54. Laitinen LV. Optimal target of pallidotomy: a controversy. In: Pallidal surgery for the treatment of Parkinson's disease and movement disorders. Krauss JK, Grossman RG, Jankovic J (editors). Philadelphia: Lippincott-Raven; 1998. pp. 285-289.
55. Vitek JL, Bakay RA, Hashimoto T, Kaneoke Y, Mewes K, Zhang JY, et al. Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease. J Neurosurg 1998; 88:1027-1043. The paper gives a detailed description and discussion on the methodology used for pallidotomy by the group that has the most experience with microelectrode mapping of the pallidum.
56. Hutchison WD, Lozano AM, Davis KD, Saint-Cyr JA, Lang AE, Dostrovsky JO. Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients. NeuroReport 1994; 5:1533-1537. The electrophysiological mapping of the STN and neighbouring structures using intraoperative microrecording is described in patients with Parkinson's disease. The authors do not rely on microstimulation for targeting.
57. Bakay RAE, Starr PA. Optimal target of pallidotomy: a controversy. In: Pallidal surgery for the treatment of Parkinson's disease and movement disorders. Krauss JK, Grossman RG, Jankovic J (editors). Philadelphia: Lippincott-Raven; 1998. pp. 275-283.
58. Krauss J, Grossman RG. Optimal target of pallidotomy: a controversy. In: Pallidal surgery for the treatment of Parkinson's disease and movement disorders. Krauss JK, Grossman RG, Jankovic J (editors). Philadelphia: Lippincott-Raven Publishers; 1998. pp. 291-296.
59. Gross RE, Lombardi WJ, Lang A, Duff J, Hutchison WD, Saint-Cyr JA, et al. Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease. Brain 1999; 122:405-416. The relationship between lesion location and clinical outcome following pallidotomy for Parkinson's disease was examined using volumetric MRI. The authors concluded that improvement in specific motor signs in Parkinson's disease after pallidotomy was related to lesion position within the posteroventral GPi. As with GPi stimulation [77-79] there was a dissociation for rigidity and dyskinesias on the one hand, and for akinesia on the other hand.
60. Trépanier LL, Saint-Cyr JA, Lozano A, Lang AE. Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology 1998; 51:207-215. In 25-30% of the patients executive behavioral control was impaired after unilateral pallidotomy, indicating that nonmotor pathways are not spared in microelectrode-guided lesions aimed at the sensorimotor GPi.
61. Lang AE, Lozano A, Tasker R, Duff J, Saint-Cyr J, Trépanier L. Neuropsychological and behavioral changes and weight gain after medial pallidotomy. Ann Neurol 1997; 41:834-836.
62. Soukup VM, Ingram F, Schiess MC, Bonnen JG, Nauta HJ, Calverley JR. Cognitive sequelae of unilateral posteroventral pallidotomy. Arch Neurol 1997; 54:947-950.
63. Masterman D, DeSalles A, Baloh R, Frysinger R, Foti D, Behnke E, et al. Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson disease. Arch Neurol 1998; 55:1201-91208.
64. Perrine K, Dogali M, Fazzini E, Sterio D, Kolodny E, Eidelberg D, et al. Cognitive functioning after pallidotomy for refractory Parkinson's disease. J Neurol Neurosurg Psychiatry 1998; 65:150-154.
65. Lim JY, DeSalles AAF, Bronstein J, Mastermann D, Saver JL. Delayed internal capsule infarctions following radiofrequency pallidotomy. J Neurosurg 1997; 87:955-960.
66. Biousse V, Newman NJ, Carroll C, Mewes K, Vitek J, Bakay RAE, et al. Visual fields in patients with posterior GPi pallidotomy. Neurology 1998; 50:258-265.
67. Golbe LI. Pallidotomy for Parkinson's disease: hitting the target? Lancet 1998; 351:998-999.
68. Gregory R. Unilateral pallidotomy for advanced Parkinson's disease [Editorial]. Brain 1999; 122:381-382.
69. Schuurman PR, DeBie RMA, Speelman JD, Bosch DA. Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients. Mov Disord 1997; 12:752-755.
70. Saint-Cyr JA. Neuropsychological impact of posteroventral pallidotomy in the treatment of Parkinson's disease. In: Teaching courses 1999. St Paul, Mn: American Academy of Neurology; 1999. pp 1-8.
71. Gross C, Rougier A, Guehl D, Boraud T, Julien J, Bioulac B. High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases. J Neurosurg 1997; 87:491-498.
72. Pahwa R, Wilkinson S, Smith D, Lyons K, Miyawaki E, Koller WC. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology 1997; 49:249-253.
73. Tronnier VM, Fogel W, Kronenbuerger M, Steinvorth S. Pallidal stimulation: an alternative to pallidotomy? Neurosurgery 1997; 87:700-705.
74. Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, Benabid AL. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998; 121:451-457. In a nonrandomized study, using a suprathreshold dose of levodopa, the levodopa-induced improvement of akinesia could be reproduced to the same degree with bilateral STN stimulation, but not with bilateral GPi stimulation. Moreover, GPi stimulation required higher stimulation parameters and, on the contrary to STN stimulation, dopaminergic medication could not be reduced. Based on these findings, the authors favour the STN for Parkinson's disease surgery.
75. Gálvez-Jiménez N, Lozano A, Tasker R, Duff J, Hutchison W, Lang AE. Pallidal stimulation in Parkinson's disease patients with a prior unilatreal pallidotomy. Can J Neurol Sci 1998; 25:300-305.
76. Siegfried J, Wellis G. Chronic electrostimulation of ventroposterolateral pallidum: follow-up. Acta Neurochirg (Wien) 1997; 68 (Suppl.):11-13.
77. Krack P, Pollak P, Limousin P, Benabid AL. Levodopa-inhibiting effect of pallidal surgery. Ann Neurol 1997; 42:129-129.
78. Bejjani B, Damier P, Arnulf I, Bonnet AM, Vidailhet M, Dormont D, et al. Pallidal stimulation for Parkinson's disease. Two targets? Neurology 1997; 49:1564-1569.
79. Krack P, Pollak P, Limousin P, Hoffmann D, Benazzouz A, Lebas JF, et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol 1998; 43:180-192. Dyskinesias were suppressed, together with rigidity, when stimulating the ventral GPi or the ansa lenticularis. Stimulation effective for these symptoms could worsen akinesia. On the other hand, akinesia was improved with stimulation of electrodes that were located more dorsally, sometimes with an increase in dyskinesias. It was possible to find a compromise between these opposite effects, with stimulation of an electrode located centrally in the GPi improving all of the symptoms. These findings confirm the results of earlier studies [77,78] and demonstrate that the pathophysiology of akinesia and rigidity is subserved by different anatomical structures within the GPi.
80. Bejjani BP, Damier P, Arnulf I, Papadopoulos S, Bonnet AM, Vidailhet M, et al. Deep brain stimulation in Parkinson's disease: opposite effects of stimulation in the pallidum. Mov Disord 1998; 13:969-970.
81. Krack P, Pollak P, Limousin P, Hoffmann D, Benazzouz A, Benabid AL. Inhibition of levodopa-effects by internal pallidal stimulation. Mov Disord 1998; 13:648-652.
82. Tröster AI, Fields JA, Wilkinson SB, Pahwa R, Miyawaki E, Lyons KE, Koller WC. Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology 1997; 49:1078-1083.
83. Vingerhoets G, van der Linden C, Lannoo E, Vanderwalle V, Caemaert J, Wolters M, Van den Abbeele D. Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease. J Neurol Neursourg Psychiatry 1999; 66:297-304.
84. Pollak P, Benabid AL, Limousin P, Benazzouz A, Hoffmann D, LeBas JF, Perret J. Subthalamic nucleus stimulation alleviates akinesia and rigidity in Parkinsonian patients. In: Battistin L, Scarlato G, Caraceni T, Ruggieri S (editors). Advances in neurology. Philadelphia: Lippincott-Raven; 1996. pp. 591-594.
85. Starr PA, Vitek JL, DeLong M, Bakay RA. Magnetic resonance imaging-based stereotactic localization of the globus pallidus and subthalamic nucleus. Neurosurgery 1999; 44:303-314. MRI-based stereotactic targeting based on direct visualization of the GPi or STN was found to be useful to improve target accuracy over that of indirect targeting methods.
86. Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang AE, Lozano AM. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998; 44:622-628.
87. Krack P, Benazzouz A, Pollak P, Limousin P, Piallat B, Hoffmann D, et al. Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord 1998; 13:907-914. This paper shows a good effect of STN stimulation on Parkinson's disease tremor, even in patients with severe tremor. With an effect similar to that of Vim stimulation, which does not improve either the other parkinsonian features or the levodopa-induced dyskinesias, the STN is proposed as the target of choice, even in tremor-dominant PD.
88. Rodriguez-Oroz MC, Guridi J, Alvarez L, Mewes K, Macias R, Vitek J, et al. The subthalamic nucleus and tremor in Parkinson's disease. Mov Disord 1998; 13 (Suppl. 3):111-118.
89. Pollak P. Deep brain stimulation. In: Teaching course on movement disorders. St Paul, MM: American Academy of Neurology; 1999. pp. 1-20.
90. Van Blercom N, Charles D, Limousin P, Krack P, Benazzouz A, Ardouin C, et al. Long-term bilateral subthalamic nucleus stimulation for the treatment of Parkinson's disease [Abstract]. Neurology 1999; 52 (Suppl 2.):A271.
91. Charles DVBN, Krack P, Xie J, Benabid AL, Pollak P. Preoperative indicators of clinical outcome following bilateral subthalamic nucleus stimulation for the treatment of Parkinson's disease [abstract]. Neurology 1999; 52 (Suppl. 2):A272.
92. Krack P, Limousin P, Benabid AL, Pollak P. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease [letter]. Lancet 1997; 350:1676.
93. Fraix V, Pollak P, Van Blercom N, Xie J, Krack P, Benabid AL. The effect of subthalamic nucleus stimulation on levodopa-induced dyskinesias in patients with Parkinson's disease [Abstract]. Neurology 1999; 52 (Suppl 2.):A403-A404.
94. Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. From off-period dystonia to peak-dose chorea: the clinical spectrum of varying subthalamic nucleus activity. Brain 1999; 122:1133-1146. Off-period dystonia, associated with neuronal hyperactivity in the STN, is directly affected by stimulation and disappears immediately. The effect of chronic high-frequency stimulation of the STN on diphasic and peak-dose dyskinesias is more complex and is related directly to the functional inhibition of the STN and indirectly to the replacement of the pulsatile dopaminergic stimulation by continuous functional inhibition of the STN. Fixed off-period dystonia, mobile diphasic dystonia and peak-dose choreodystonia seem to represent a continuous clinical spectrum of underlying activity patterns in STN neurones.
95. Limousin P, Pollak P, Hoffmann D, Benazzouz A, Benabid AL. Abnormal involuntary movements induced by subthalamic nucleus stimulation on Parkinsonian patients. Mov Disord 1996; 11:231-235.
96. Brown RG, Limousin Dowsey P, Brown P, Jahanshahi M, Pollak P, Benabid AL, et al. Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease. Ann Neurol 1999; 45:473-488. The effects of DBS of the STN and GPi on upper limb akinesia in Parkinson's disease were carefully examined. Stimulation improved movement time and force production to a larger extent than initiation time. Repetitive movements involving fine distal coordination showed only very modest improvements compared with proximal ballistic tasks. The STN group tended to show somewhat more benefit from stimulation on many of the measures, but the differences were minor, and were only quantitative, not qualitative. The effects of DBS of both targets were similar to the effects of unilateral pallidal lesions [40]. The authors suggested that disrupted pallidal outflow is the most important determinant of upper limb akinesia.
97. Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease [letter]. Lancet 1997; 350:1675.
98. Pollak P, Benabid AL, Gross C, Gao DM, Laurent A, Benazzouz A, et al. Effets de la stimulation du noyau sousthalamique dans la maladie de Parkinson [in French]. Rev Neurol 1993; 149:175-176.
99. Damier P, Derneret S, Bejjani BP, Arnulf I, Gervais D, Agid Y. Does unilateral subthalamic stimulation only improve contralateral parkinsonian signs? [Abstract]. Neurology 1999; 52 (Suppl 2.):A272.
100. Kumar RLA, Sime E, Halket E, Lang AE. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. 1999 Neurology: (in press).
101. Krack P, Gentil M, Pinto S, Benabid AL, Pollak P. Effects of subthalamic nucleus stimulation on parkinsonian speech [Abstract XIII International congress on Parkinson's disease]. Parkinsonism and Related Disorders 1999: (in press).
102. Ardouin C, Klinger H, Limousin P, Krack P, Xie J, Van Blercom N, et al. The effect of bilateral subthalamic nucleus stimulation on cognitive functions [Abstract]. Neurology 1999; 52 (Suppl 2.):A514.
103. Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 1997; 42:283-291.
104. Kumar R, Krack P, Pollak P. Laughter induced by subthalamic nucleus deep brain stimulation [letter]. N Engl J Med 1999: (in press).
105. Bejjani BP, Damier P, Arnulf I, Thivard L, Bonnet AM, Dormont D, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999; 340:1476-1480.
106. Guridi J, Obeso JA. The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: new surgical perspectives. In: The basal ganglia and new surgical approaches for Parkinson's disease. Advances in Neurology, vol. 74. Obeso JA, DeLong MR, Ohye C, Marsden CD (editors). Philadelphia: Lippincott-Raven; 1997. pp. 235-247.
107. Gill SS, Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease [letter]. Lancet 1997; 350:1224.
108. Gill SS, Heywood P. Bilateral subthalamic nucleotomy can be accomplished safely [abstract]. Mov Disord 1998; 13 (Suppl. 2):201.
109. Inzelberg R, Korczyn AD. Persistent hemiballismus in Parkinson's disease [letter]. J Neurol Neurosurg Psychiatry 1994; 57:1013.
110. Piallat B, Benazzouz A, Benabid AL. Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease. J Neural Transm Suppl 1999; 55:71-77.
111. Rodriguez MC, Obeso JA, Olanow CW. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 1998; 44 (Suppl. 1):S175-S188.
112. Tasker RR, Siqueira J, Hawrylyshyn P, Organ LW. What happened to VIM thalamotomy for Parkinson's disease? Appl Neurophysiol 1983; 46:68-83.
113. Narabayashi H, Yokochi F, Nakajima Y. Levodopa-induced dyskinesia and thalamotomy. J Neurol Neurosurg Psychiatry 1984; 47:831-839.
114. Speelman JD. Parkinson's disease and stereotaxic neurosurgery. Amsterdam: Rodopi; 1991.
115. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease. Appl Neurophysiol 1987; 30:344-346.
116. Caparros Lefebvre D, Blond S, Vermersch P, Pecheux N, Guieu JD. Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993; 56:268-273.
117. Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology 1998; 51:1063-1069.
118. Tasker RR. Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg Neurol 1998; 49:145-153.
119. Koller W, Pahwa R, Busenbark K, Hubble J, Wilkinson S, Lang A, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997; 42:292-299.
120. Limousin P, Speelman JD, Gielen F, Janssens M, and the study collaborators. Multicenter European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 1999; 66:289-296.
121. Narabayashi H, Miyashita N, Hattori Y, Saito K, Endo K. Posteroventral pallidotomy: its effect on motor symptoms and scores of MMPI test in patients with Parkinson's disease. Parkinsonism Related Disord 1997; 3:7-20.
122. Hariz MI, Fodstad H. 'The pallidotomy debate': are micro-electrode-guided pallidotomies always located in the pallidum [reply to Aziz TZ, Munro-Davies LE]. Br J Neurosurg 1998; 12:595-597.
123. Tsao K, Wilkinson S, Overman J, Koller WC, Batnitzky S, Gordon MA. Pallidotomy lesion locations: significance of microelectrode refinement. Neurosurgery 1998; 43:506-512. (discussion 512-513.)
124. Kelly PJ. Pallidotomy lesion location: significance of microelectrode refinement-comment. Neurosurgery 1998; 43:512.
125. Tasker RR. Pallidotomy lesion locations: significance of microelectrode refinement-comment. Neurosurgery 1998; 43:512.
126. Burchiel KJ: Pallidotomy lesion locations: significance of microelectrode refinement-comment. Neurosurgery 1998; 43:512-513.
127. Bakay RAE. Pallidotomy lesion locations: significance of microelectrode refinement-comment. Neurosurgery 1998; 43:513.
128. Alterman RL, Sterio D, Beric A, Kelly PJ. Microelectrode recording during posteroventral pallidotomy: impact on target selection and complications. Neurosurgery 1999; 44:315-321.
129. Gross RE, Lombardi WJ, Hutchison WD, Narula S, Saint-Cyr JA, Dostrovsky JO, et al. Variability in lesion location after microelectrode-guided pallidotomy for Parkinson's disease: anatomical, physiological, and technical factors that determine lesion distribution. J Neurosurg 1999; 90:468-477.
130. Laitinen LV. Ablative surgery and deep brain stimulation for Parkinson's disease-comments. Neurosurgery 1999; 43:1013-1014.
131. Benabid AL, Benazzouz A, Hoffmann D, Limousin P, Krack P, Pollak P. Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord 1998; 13 (Suppl. 3):119-125.
132. Alterman RL, Kelly P. Magnetic resonance imaging guidance in surgery for Parkinson's disease. In: Neurosurgical treatment of movement disorders. Germano IM (editor). Park Ridge: AANS; 1998. pp. 195-205.
133. Dormont D, Zerah M, Cornu P, Parker F, Aubert B, Sigal R, et al. A technique of measuring the precision of an MR-guided stereotaxic installation using anatomic specimens. Am J Neuroradiol 1994; 15:365-371.
134. Favre J, Taha JM, Nguyen TT, Gildenberg PL, Burchiel KJ. Pallidotomy: a survey of current practice in North America. Neurosurgery 1996; 39:883-890.
135. Hartz MI. Decrease in akinesia seems to result from chronic electrical stimulation in the external (GPe) rather than internal (GPi) pallidum [letter]. Mov Disord 1999;536.
136. Krack P, Pollak P, Limousin P, Hoffman D, Benazzouz A, Benabid AL. Decrease in akinesia seems to result from chronic electrical stimulation in the external (GPe) rather than internal (GPi) pallidum - reply. Mov Disord 1999:537-539.
137. Starr PA, Vitek J, Bakay AE. Ablative surgery and deep brain stimulation for Parkinson's disease. Neurosurgery 1999; 43:989-1015.
138. Schuurman PR, Speelman JD, Bosch DA. Thalamic stimulation versus thalamotomy in a prospective randomized trial [abstract]. Acta Neurochirurg 1998; 140:838.